Bitran D, Hilvers R J, Frye C A, Erskine M S
Department of Psychology, College of the Holy Cross, Worcester, MA 01610, USA.
Life Sci. 1996;58(7):573-83. doi: 10.1016/0024-3205(95)02326-7.
Previous research in this laboratory has shown that chronic treatment of adult male rats with an anabolic-androgenic steroid (AAS) produced anxiolytic behavior and increased the functional response of cortical gamma-aminobutyric acid(A) (GABA(A)) receptors. The experiments reported here were aimed at further characterizing the effect of chronic AAS exposure on cerebral cortical GABA(A) receptors. Adult male rats were injected with dianabol (1,4-androstadien-17alpha-methyl-17beta-ol-3-one; 10 mg/kg/day, SC) for 4 weeks. A significant decrease in ventral prostate gland weight was found after 2 weeks of dianabol, and returned to control levels 3 and 10 days after steroid discontinuation. Testicular weights decreased throughout the treatment period but reached statistical significance only during the withdrawal period. Serum 3alpha-androstanediol level was marginally increased afer 2 weeks of dianabol injection, and was significantly decreased at 3 and 10 days after withdrawal. GABA-stimulated 36chloride (Cl-) influx in cortical synaptoneurosomes was increased in animals treated with dianabol for 2 and 4 weeks, and remained elevated 3 days after dianabol withdrawal, returning to control levels at withdrawal day 10. The increase in receptor efficacy was associated with a transient increase in receptor sensitivity (inverse of EC50), apparent after 2 weeks of AAS treatment and at withdrawal day 3. In a follow-up experiment, metabolites of dianabol were tested for the in vitro efficacy in potentiating GABA-stimulated Cl- transport. Only 3alpha-androstanedial and androsterone were found to have potent stimulatory effects. The 3beta-reduced metabolites were inactive, as were metabolites that contained a methyl group at the 17alpha position. These results point to significant facilitative effects of dianabol treatment on brain GABA(A) receptors via the metabolic formation of neuroactive steroids.
本实验室先前的研究表明,用合成代谢雄激素类固醇(AAS)对成年雄性大鼠进行长期治疗会产生抗焦虑行为,并增加皮质γ-氨基丁酸A(GABA(A))受体的功能反应。本文报道的实验旨在进一步表征长期暴露于AAS对大脑皮质GABA(A)受体的影响。成年雄性大鼠皮下注射大力补(1,4-雄甾二烯-17α-甲基-17β-醇-3-酮;10毫克/千克/天),持续4周。大力补注射2周后,腹侧前列腺重量显著降低,并在停用类固醇后3天和10天恢复到对照水平。整个治疗期间睾丸重量均下降,但仅在撤药期达到统计学显著性。大力补注射2周后,血清3α-雄烷二醇水平略有升高,并在撤药后3天和10天显著降低。在用大力补治疗2周和4周的动物中,GABA刺激的皮质突触神经小体中36氯(Cl-)内流增加,在停用大力补3天后仍保持升高,在撤药第10天恢复到对照水平。受体效能的增加与受体敏感性(EC50的倒数)的短暂增加有关,在AAS治疗2周后和撤药第3天明显。在后续实验中,测试了大力补的代谢产物在体外增强GABA刺激的Cl-转运的效能。仅发现3α-雄烷二醇和雄酮具有强效刺激作用。3β-还原代谢产物无活性,17α位含甲基的代谢产物也无活性。这些结果表明,大力补治疗通过神经活性类固醇的代谢形成对脑GABA(A)受体具有显著的促进作用。